Filing Details
- Accession Number:
- 0001144204-12-053220
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-27 16:02:27
- Reporting Period:
- 2012-09-20
- Filing Date:
- 2012-09-27
- Accepted Time:
- 2012-09-27 16:02:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138776 | Medgenics Inc. | MDGN | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1516546 | K. Phyllis Bellin | 555 California Street, Suite 365 San Francisco CA 94104 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-09-20 | 5,082 | $10.92 | 11,064 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-09-21 | 400 | $10.90 | 10,664 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.01, inclusive. The reporting person undertakes to provide Medgenics, Inc., any security holder of Medgenics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These shares were sold in multiple transactions, each at a price of $10.90. The reporting person undertakes to provide Medgenics, Inc., any security holder of Medgenics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
Billionaire Hedge Funds
